APGE icon

Apogee Therapeutics
APGE

Upgrade to unlock
Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$105
49% upside
High target

4 analyst ratings

positive
1  neutral
25%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
RBC Capital
RBC Capital
Brian Abrahams
100% 1-yr APGE win rate
22 Jan ‘26 1 month ago
Wolfe Research
Wolfe Research
Andy Chen
7 Jan ‘26 1 month ago
BTIG
BTIG
Julian Harrison
67% 1-yr APGE win rate
6 Jan ‘26 1 month ago
Stephens & Co
Stephens & Co
Sudan Loganathan
0% 1-yr APGE win rate
17 Dec ‘25 2 months ago
Deutsche Bank
Deutsche Bank
David Hoang
0% 1-yr APGE win rate
10 Dec ‘25 2 months ago